Novel composition for treating psoriasis

A technology of psoriasis and composition, which is applied in the field of new composition for treating psoriasis, can solve problems such as side effects, and achieve the effect of not easy to relapse, simple preparation process and remarkable effect

Inactive Publication Date: 2021-04-13
烟台心舒医药科技有限公司
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, long-term use may cause side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel composition for treating psoriasis
  • Novel composition for treating psoriasis
  • Novel composition for treating psoriasis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] A novel composition for treating psoriasis, comprising the following components in parts by weight: 0.005 parts of ethyl aryretinoin, 1 part of polypeptide, 0.07 parts of ribose, 15 parts of terfenadine, 50 parts of vitamin E, ammonia 500 parts of peptide peptide, 50 parts of aminophylline, 1 part of chlorpheniramine maleate, 100 parts of vitamin C, 13 parts of vitamin B, 1.5 parts of vitamin B, 10 parts of tripterygium glycosides, 4.58 parts of microcrystalline cellulose, 3.33 parts of pregelatinized starch, 6.67 parts of crospovidone, and 1 part of talcum powder; wherein the pregelatinized starch is 1500 parts, and the crospovidone is PVP K30.

[0043] Described composition is oral capsule, and its preparation method comprises:

[0044] Step a: Take each component according to the weight ratio of the above components, place them in a mixer and mix them uniformly, and use the obtained composition for later use;

[0045] Step b: passing the composition in step a throug...

Embodiment 2

[0049] A novel composition for treating psoriasis, comprising the following components in parts by weight: 0.02 parts of ethyl aryretinoin, 6 parts of polypeptide, 0.27 parts of ribose, 60 parts of terfenadine, 200 parts of vitamin E, ammonia Copeptide 2000 parts, aminophylline 200 parts, chlorpheniramine maleate 10 parts, vitamin C 400 parts, vitamin B112 parts, vitamin B210 parts, tripterygium glycosides 40 parts, microcrystalline cellulose 18.33 parts, pregelatinized 13.33 parts of starch, 26.67 parts of crospovidone, and 4 parts of talcum powder; among them, the pregelatinized starch is 1500 parts, and the crospovidone is PVP K30.

[0050] Described composition is oral tablet, and its preparation method comprises:

[0051] Step a: Take each component according to the weight ratio of the above components, place them in a mixer and mix them uniformly, and use the obtained composition for later use;

[0052] Step b: the composition in step a is placed in a tablet press, and ...

Embodiment 3

[0055] A novel composition for treating psoriasis, comprising the following components in parts by weight: 0.01 part of ethyl aryretinoin, 3.5 parts of polypeptide, 0.15 part of ribose, 35 parts of terfenadine, 130 parts of vitamin E, ammonia Copeptide 1200 parts, aminophylline 130 parts, chlorpheniramine maleate 5 parts, vitamin C 250 parts, vitamin B17 parts, vitamin B26 parts, tripterygium glycosides 25 parts, microcrystalline cellulose 11 parts, pregelatinized 8 parts of starch, 16 parts of crospovidone, and 2.5 parts of talcum powder; among them, the pregelatinized starch is 1500 parts, and the crospovidone is PVP K30.

[0056] Described composition is oral capsule, and its preparation method comprises:

[0057] Step a: Take each component according to the weight ratio of the above components, place them in a mixer and mix them uniformly, and prepare the obtained composition for later use;

[0058] Step b: passing the composition in step a through a 100-mesh sieve to obt...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a novel composition for treating psoriasis. The composition comprises the following components of, in parts by weight, 0.005-0.02 parts of arotinoid ethylester, 1-6 parts of polypeptide, 0.07-0.27 parts of ribose, 15-60 parts of terfenadine, 50-200 parts of vitamin E, 500-2000 parts of aminopeptide, 50-200 parts of aminophylline, 1-10 parts of chlorpheniramine maleate, 100-400 parts of vitamin C, 3-12 parts, 1.5-10 parts of vitamin B2, 10-40 parts of tripterygium glycosides, 4.58-18.33 parts of microcrystalline cellulose, 3.33-13.33 parts of pregelatinized starch, 6.67-26.67 parts of polyvinylpolypyrrolidone and 1-4 parts of talcum powder. The invention provides a method for treating psoriasis by combining traditional Chinese medicines and western medicines. Based on gene regulation and transfer termination of inflammatory factors, cellular immunity and humoral immunity are enhanced at the same time, and the purpose of treating both symptoms and root causes is finally achieved.

Description

technical field [0001] The invention belongs to the field of medicines, in particular to a novel composition for treating psoriasis. Background technique [0002] Psoriasis has been called chronic disease since ancient times, it is a chronic disease, and it is extremely easy to relapse. Patients often have silvery-white scales, and after the scales fall off, bright red spots will be exposed. Psoriasis usually worsens in winter. [0003] Psoriasis broadly falls into four categories: [0004] (1) Psoriasis vulgaris: It is the most common clinical type, relatively mild, mainly manifested as scaly erythema and papules. Accounts for more than 95% of psoriasis. [0005] (2) Pustular psoriasis: usually caused by untreated psoriasis vulgaris, wrong treatment or other factors, pustules from needle tip to miliary grain size can be seen on the skin lesions, some pustules merge to form a pus lake, accompanied by fever , chills, elevated white blood cells, etc. It is a relatively r...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/02A61K9/20A61P17/06A61K31/216A61K31/355A61K31/375A61K31/4402A61K31/445A61K31/51A61K31/522A61K31/525A61K31/70A61K36/37
CPCA61K9/2009A61K9/2027A61K9/2054A61K9/2059A61K31/216A61K31/355A61K31/375A61K31/4402A61K31/445A61K31/51A61K31/522A61K31/525A61K31/70A61K36/37A61K38/02A61P17/06A61K2300/00
Inventor 任俊伟刘汉朴曹立新董博华张玥张灿辉臧传福张孝顺曲拥措姆张谷朔宋光耀邢明明李妍锌赵志鹏丁保华张春凤夏水苗李缘郑晓龙杨节才闫茂鑫高天羽
Owner 烟台心舒医药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap